Addressing Your Pain Points If you are a laboratory researcher, procurement officer, or academic scientist, you already know the frustration of sourcing peptides from suppliers who cannot provide adequate documentation
About this article Cite this article Sahiner, U.M., Birben, E., Erzurum, S
Insights like these support the development of earlier detection tools, better identification of risk, and more targeted treatment approaches
Furthermore, owing to the limited number of therapeutic drugs, along with the emergence of drug-resistant strains, the clinical treatment of C
Cytochrome P450 family 51 subfamily A member 1 (CYP51A1), a conserved sterol 14-demethylase essential for cholesterol synthesis, exemplifies this emerging concept